沙利度胺在移植物抗宿主病治疗中的潜在应用——临床与实验室信息综述
The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information.
作者信息
Wood P M, Proctor S J
机构信息
Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, U.K.
出版信息
Leuk Res. 1990;14(5):395-9. doi: 10.1016/0145-2126(90)90024-4.
Abstract
This article reviews the historical development of thalidomide as an immunosuppressive agent and the current state of knowledge of thalidomide as an anti-graft-versus-host disease (GVHD) agent. The evidence suggests that metabolites of thalidomide act at an early stage in the antigen recognition-activation pathway of graft T lymphocytes and down regulate normal lymphocyte responses. This effect seems to have beneficial effects in both acute and chronic GVHD, but the optimal mode of use in the clinical setting remains to be determined.
摘要
本文回顾了沙利度胺作为免疫抑制剂的历史发展以及沙利度胺作为抗移植物抗宿主病（GVHD）药物的当前知识状况。证据表明，沙利度胺的代谢产物在移植T淋巴细胞的抗原识别-激活途径的早期起作用，并下调正常淋巴细胞反应。这种作用似乎在急性和慢性GVHD中都有有益效果，但在临床环境中的最佳使用方式仍有待确定。
相似文献
1
The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information.沙利度胺在移植物抗宿主病治疗中的潜在应用——临床与实验室信息综述
Leuk Res. 1990;14(5):395-9. doi: 10.1016/0145-2126(90)90024-4.
2
Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model.沙利度胺在大鼠模型中治疗和预防急性移植物抗宿主病
Transplantation. 1986 May;41(5):644-7. doi: 10.1097/00007890-198605000-00018.
3
Thalidomide for treatment of graft-versus-host disease.沙利度胺用于治疗移植物抗宿主病。
Bone Marrow Transplant. 1988 Sep;3(5):393-8.
4
The use of thalidomide in chronic refractory graft versus host disease.沙利度胺在慢性难治性移植物抗宿主病中的应用。
Neth J Med. 2001 Aug;59(2):45-9. doi: 10.1016/s0300-2977(01)00133-4.
5
Graft-versus-host disease.移植物抗宿主病
Curr Opin Oncol. 1994 Jul;6(4):358-64. doi: 10.1097/00001622-199407000-00006.
6
Thalidomide for chronic GVHD.
Bone Marrow Transplant. 1998 Nov;22(9):933-4. doi: 10.1038/sj.bmt.1701467.
7
Thalidomide for the treatment of chronic graft-versus-host disease.沙利度胺用于治疗慢性移植物抗宿主病。
N Engl J Med. 1992 Apr 16;326(16):1055-8. doi: 10.1056/NEJM199204163261604.
8
Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature.
Pediatrics. 1999 Apr;103(4):e44. doi: 10.1542/peds.103.4.e44.
9
Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.沙利度胺用于治疗或预防慢性移植物抗宿主病的评估。
Leuk Lymphoma. 2003 Jul;44(7):1141-6. doi: 10.1080/1042819031000079096.
10
Response to thalidomide therapy in refractory chronic graft-versus-host disease.沙利度胺治疗难治性慢性移植物抗宿主病的疗效
Bone Marrow Transplant. 2000 Oct;26(8):865-9. doi: 10.1038/sj.bmt.1702626.
引用本文的文献
1
Management of graft-versus-host disease in paediatric bone marrow transplant recipients.儿童骨髓移植受者移植物抗宿主病的管理
Paediatr Drugs. 2000 Jan-Feb;2(1):29-55. doi: 10.2165/00148581-200002010-00004.
2
Thalidomide: rationale for renewed use in immunological disorders.沙利度胺：在免疫性疾病中重新应用的理论依据。
Drug Saf. 1995 Jun;12(6):364-9. doi: 10.2165/00002018-199512060-00002.
3
Oral complications of cancer.癌症的口腔并发症
BMJ. 1991 Apr 6;302(6780):848.
4
Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.沙利度胺用于人类免疫缺陷病毒（HIV）患者。安全性考量综述。
Drug Saf. 1992 Mar-Apr;7(2):116-34. doi: 10.2165/00002018-199207020-00004.
本文引用的文献
1
[Thalidomide embryopathy].[沙利度胺胚胎病]
Dtsch Med Wochenschr. 1962 Jun 15;87:1232-42. doi: 10.1055/s-0028-1111892.
2
PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE.沙利度胺延长皮肤同种异体移植存活时间
Br Med J. 1965 Sep 18;2(5463):687-9. doi: 10.1136/bmj.2.5463.687.
3
THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS.沙利度胺治疗麻风反应
Clin Pharmacol Ther. 1965 May-Jun;6:303-6. doi: 10.1002/cpt196563303.
4
Marrow transplants in lethally irradiated dogs given methotrexate.对接受甲氨蝶呤治疗的经致死剂量照射的犬进行骨髓移植。
Blood. 1962 Feb;19:217-28.
5
Alteration of homograft reaction by A-methopterin in lethally irradiated mice treated with homologous marrow.
Proc Soc Exp Biol Med. 1958 Dec;99(3):651-3. doi: 10.3181/00379727-99-24450.
6
Response of graft versus host disease to high doses of methyl prednisolone.
Clin Lab Haematol. 1981;3(1):19-26. doi: 10.1111/j.1365-2257.1981.tb01305.x.
7
Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions.
J Am Acad Dermatol. 1982 Sep;7(3):317-23. doi: 10.1016/s0190-9622(82)70118-5.
8
Use of cyclosporin A (CsA) in a rat model of allogeneic marrow transplantation.环孢素A（CsA）在同种异体骨髓移植大鼠模型中的应用。
Haematol Blood Transfus. 1980;25:241-53. doi: 10.1007/978-3-642-67319-1_20.
9
10
Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.沙利度胺致畸作用：有毒芳烃氧化物代谢物的证据。
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2545-8. doi: 10.1073/pnas.78.4.2545.
Zotero 插件